- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
HLS
ASX
Week ended 07 Aug 2026
Weekly Investor Report
Healius Limited · Healthcare · Diagnostics & Research
Latest close
0.42 AUD
12.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -21.6% below the Trend Line and sits at 15.0% of its 52-week range. The latest completed week returned 12.0%, after a 9.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
33
out of 100
Latest Close
0.42 AUD
7 Aug 2026
1W Return
12.0%
latest completed week
4W Return
9.1%
short-term follow-through
12W Return
21.7%
quarterly tape
Trend Breadth
21.2%
11 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 40.45% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
12.0%
Latest completed week; four-week move 9.1%.
Indicator stack
12/75
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.45%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
24 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -21.6% below the Trend Line and sits at 15.0% of its 52-week range. The latest completed week returned 12.0%, after a 9.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0512-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 9.1% over four weeks, 21.7% over 12 weeks, and -50.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year11
Trend breadth21.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.34Latest activity-pressure read.
Pressure change233.6%Four-week change in activity pressure.
Leadership-40.98Latest relative-leadership reading.
RS change10.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 30 Jun 2025
Field coverage 76%
Model confidence 39%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength47/100Blend of value, momentum, and quality. Underlying universe rank 54; rank 1 is best.
Value90/100Relative valuation strength. Underlying universe rank 11; rank 1 is best.
Quality12/100Profitability and accounting quality. Underlying universe rank 89; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth6/100Revenue and earnings growth. Underlying universe rank 95; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.2x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 19.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 84.1% Gross profit retained from each unit of revenue.
- Operating margin
- 0.0% Operating profit retained from revenue.
- Free-cash-flow margin
- 16.4% Free cash flow generated from revenue.
- Return on invested capital
- 0.0% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -23.0% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 8.4% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 98.3% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 98.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -2.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 24 relevant articles.
4 positive · 17 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-60.7%Distance below the 52-week high.
13-week volatility11.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher8 of 2617 weeks finished lower.
Best week+13.9%Week of 19 Jun.
Worst week-30.3%Week of 15 May.
Latest week+12.0%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains2
Flat weeks1
Modest losses5
Sharp losses12
Recent vol11.3%13-week weekly-return volatility.
Base vol7.2%52-week weekly-return volatility.
Up/down split17/30Count of positive and negative weeks in the 52-week window.
Average skew6.4% / -5.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Healthcare
4-week rank20 / 100
Group average-0.9%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD58.0%positive activity pressure
RS26.0%positive relative leadership
Four-week leaders
IndustryAU Diagnostics & Research
4-week rank3 / 14
Group average2.1%
Trend breadth14.3%
Trend14.3%active weekly trend signals
MD50.0%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape25/100
Trend, activity pressure, participation, and risk combine to a 25/100 tape read.
Indicator analysis14/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.05; No reversal markers Next-Week ExpectancyNegative 40.45%Next-week expectancy is negative with a 40.45% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors37/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 57; Small Cap Core rank 6 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 24 relevant articles.
Healius (ASX: HLS): Recovery Mode After Lumus Sale? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.42 AUD | 12.0% | 0.54 AUD | 0.95 AUD | 0.34 | -40.98 | 13.7M | Off |
| 31 Jul 2026 | 0.38 AUD | 7.1% | 0.55 AUD | 0.96 AUD | 0.17 | -46.30 | 12.2M | Off |
| 24 Jul 2026 | 0.35 AUD | -6.7% | 0.57 AUD | 0.97 AUD | 0.02 | -49.28 | 13.5M | Off |
| 17 Jul 2026 | 0.38 AUD | -2.6% | 0.59 AUD | 0.98 AUD | -0.12 | -46.49 | 8.8M | Off |
| 10 Jul 2026 | 0.39 AUD | 2.7% | 0.61 AUD | 0.99 AUD | -0.26 | -45.73 | 10.0M | Off |
| 3 Jul 2026 | 0.38 AUD | 2.7% | 0.63 AUD | 1.00 AUD | -0.57 | -47.92 | 715.2K | Off |
| 26 Jun 2026 | 0.36 AUD | -11.0% | 0.65 AUD | 1.01 AUD | -0.75 | -49.35 | 4.2M | Off |
| 19 Jun 2026 | 0.41 AUD | 13.9% | 0.67 AUD | 1.03 AUD | -0.96 | -44.20 | 6.9M | Off |
| 12 Jun 2026 | 0.36 AUD | 10.8% | 0.69 AUD | 1.04 AUD | -1.16 | -51.34 | 7.1M | Off |
| 5 Jun 2026 | 0.33 AUD | -4.4% | 0.70 AUD | 1.05 AUD | -1.11 | -55.72 | 26.0M | Off |
| 29 May 2026 | 0.34 AUD | -5.6% | 0.72 AUD | 1.06 AUD | -1.15 | -54.85 | 7.6M | Off |
| 22 May 2026 | 0.36 AUD | 4.3% | 0.74 AUD | 1.07 AUD | -1.18 | -52.47 | 20.2M | Off |
| 15 May 2026 | 0.34 AUD | -30.3% | 0.76 AUD | 1.08 AUD | -1.09 | -55.05 | 59.9M | Off |
| 8 May 2026 | 0.49 AUD | 0.0% | 0.77 AUD | 1.09 AUD | -1.18 | -37.56 | 18.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.